Emma C Mann
September 16, 2024 | Law.com
Federal Circuit Decision Clarifies Obviousness-Type Double Patenting and Patent Term Adjustments In 'Allergan v. MSN Laboratories'On August 13, the Federal Circuit issued a precedential ruling that reversed the District of Delaware's application of the Federal Circuit precedent in In re: Cellect to invalidate a claim in an earlier-filed parent application over admittedly patentably indistinct claims in later-filed (and earlier-expired) child patents. This decision has resolved some substantial questions about the application of obviousness-type double patenting that had been raised by last year's In re Cellect decision.
By Maia H. Harris and Emma C. Mann
7 minute read
Trending Stories
- 1Where Do Web-Tracking Class Actions Belong? 8th Circuit Weighs the Issue
- 2While Data Breaches May Lead to Years of Legal Battles, Cyberattacks Can be Prevented
- 3The Definition of Special Employment
- 4People in the News—Nov. 21, 2024—Willig Williams, Hangley Aronchick
- 5Rawle & Henderson Hires New Del. Managing Partner
More from ALM
- Legal Speak at General Counsel Conference East 2024: Virginia Griffith, Director of Business Development at OutsideGC 1 minute read
- Legal Speak at General Counsel Conference East 2024: Bill Tanenbaum, Partner & Chair, AI & Data Law Practice Group at Moses Singer 1 minute read
- Legal Speak at General Counsel Conference East 2024: Julie Cantor, Associate General Counsel at Studs, Inc. 1 minute read